Back
Cellectar Biosciences 10K Form
Sell
43
CLRB
Cellectar Biosciences
Last Price:
$0.31
Seasonality Move:
2.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLRB News And Ratings
See the #1 stock for the next 7 days that we like better than CLRB
CLRB Financial Statistics
Sales & Book Value
Annual Sales: | $0 |
---|---|
Cash Flow: | $-9.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.04 |
Price / Book: | 8.23 |
Profitability
EPS (TTM): | -1.90000 |
---|---|
Net Income (TTM): | $-50.1M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Cellectar Biosciences Earnings Forecast
Key Cellectar Biosciences Financial Ratios
-
The Interest Expense is 0.00% of Operating Income.
-
Per Share Earnings over the last 19 years have been positive in 15 years.
Cellectar Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CLRB |
CUSIP: | 15117F |
Website: | cellectar.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CLRB Technical Analysis vs Fundamental Analysis
Sell
43
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.31. The Score for CLRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.